腹膜透析退出原因分析

目的探讨尿毒症患者行腹膜透析后退出原因。方法 2012年2月-2014年3月在我院确诊为尿毒症,行腹膜透析替代治疗的64例患者,其中有7例死亡,3例转血透,分析其退出腹膜透析的原因。结果 64例患者中退出的共10例,其中3例转血透(30%),4例死于心脑血管因素(40%),死于腹腔感染1例(10%),1例死于原发病(10%)。结论导致尿毒症患者退出腹膜透析的原因中,腹腔感染已不是第一位,对于心脑血管并发症的干预,是降低患者退出腹膜透析的重要手段。

Objective To investigate the clinical treatment and curative effect in patients with peptic ulcer.Methods the clinical data of 68 cases of peptic ulcer were analyzed retrospectively,randomly divided into treatment group and control group with 34 cases in each group;the treatment group received lansoprazole,the control group were treated with omeprazole treatment,observed and compared the clinical effects of two groups.Results the two groups of patients after 1weeks of treatment,28 cases of treatment group alleviated symptoms,the control group 15 patients,the comparison between the two groups,the difference was statistically significant(P<0.05).Conclusion the application of lansoprazole in the treatment of peptic ulcer,analgesic effect,the clinical effect is obvious,it is worthy of clinical application.